Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

227 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Allogeneic versus autologous bone marrow transplantation versus chemotherapy for treatment of acute myeloid leukemia in first complete remission (BGM 84 and BGMT 87 studies). The BGMT Group.
Reiffers J, Stoppa AM, Rigal-Huguet F, Michallet M, Marit G, Gastaut JA, Attal M, Corront B, Broustet A, Hollard D, et al. Reiffers J, et al. Among authors: marit g. Bone Marrow Transplant. 1991;7 Suppl 2:36. Bone Marrow Transplant. 1991. PMID: 1878709 Clinical Trial. No abstract available.
Comparison of allogeneic or autologous bone marrow transplantation and chemotherapy in patients with acute myeloid leukaemia in first remission: a prospective controlled trial.
Reiffers J, Gaspard MH, Maraninchi D, Michallet M, Marit G, Stoppa AM, Corront B, David B, Gastaut JA, Scotto JJ, et al. Reiffers J, et al. Among authors: marit g. Br J Haematol. 1989 May;72(1):57-63. doi: 10.1111/j.1365-2141.1989.tb07652.x. Br J Haematol. 1989. PMID: 2660902 Clinical Trial.
Autografting in chronic myeloid leukemia: an overview.
Reiffers J, Mahon FX, Boiron JM, Fabères C, Marit G, Cony-Makhoul P, Broustet A. Reiffers J, et al. Among authors: marit g. Leukemia. 1996 Mar;10(3):385-8. Leukemia. 1996. PMID: 8642851 Review.
A prospective randomized trial of idarubicin vs daunorubicin in combination chemotherapy for acute myelogenous leukemia of the age group 55 to 75.
Reiffers J, Huguet F, Stoppa AM, Molina L, Marit G, Attal M, Gastaut JA, Michallet M, Lepeu G, Broustet A, Pris J, Maraninchi D, Hollard D, Fabères C, Mercier M, Hurteloup P, Danel P, Tellier Z, Berthaud P. Reiffers J, et al. Among authors: marit g. Leukemia. 1996 Mar;10(3):389-95. Leukemia. 1996. PMID: 8642852 Clinical Trial.
227 results